The USDSI Certified Data Science Professional (CDSP) program equips learners with industry-ready skills in Data Science, ...

A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely ...

A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, ...

People who received an infusion of stem cells shortly after a heart attack were less likely to develop heart failure than those treated with standard care, according to the largest such trial to date.

The AICPA and state societies have pledged strong support for accounting education programs to gain STEM status, and the idea also has backing from the majority of respondents in a new survey. A ...

Stem reported fiscal 2025 second-quarter revenue of $38.37 million, up 12.9% year-over-year and beating estimates by $5.9 million. Gross profit margin for STEM rose to 33.36%, reflecting a positive ...

Traveling to space is brutal on the body. Spaceflight can cause astronauts’ bones to lose density, their brain and eye nerves to swell, and their genes to change expression. Research suggests spending ...

Spaceflight makes certain human stem cells age faster, a new study has found, furthering scientists’ understanding of the potential effects of space exploration on the human body. Stem cells are found ...

Knoepfler is STAT’s Lab Dish columnist and professor of cell biology and human anatomy at UC Davis School of Medicine. Japanese regulators just quietly gave researchers there a historic OK to generate ...

Several people described the energy at Riverview STEM Academy Thursday morning as “electric” — a fitting term for a K-6 (and soon to be K-8) school focused on technology and science. Teachers, ...

Florida is the latest state to sidestep the authority of the Food and Drug Administration by allowing patients to access certain stem-cell treatments that have not been rigorously evaluated and ...